A comparative view of the market changes which opportunities a hospital is able to fund and defend.
By Julie Amor, MHA Chief Strategy Officer, Onspire Health Marketing
Most hospital chief executives understand their markets in considerable depth. They know which competitors have gained ground over the past several years, which service lines carry unrealized potential, and what physicians, employees and community members say about the organization. Many have led in the same region for a decade or more. Others arrived with long experience in organizations of similar size and circumstance. That accumulated judgment is a genuine asset, and it is usually accurate.
What judgment cannot produce on its own is measurement. A chief executive may hold a well-founded conviction that orthopedic volume is leaving the service area. Establishing how much volume, which providers received it, and what portion might realistically return requires a different kind of work. The distinction has nothing to do with competence; it is a question of vantage point, and vantage point is not something experience can overcome.
That distinction — between what an organization understands and what it can demonstrate — determines a great deal about which opportunities receive funding and which remain convictions.
The limits of an internal view
Every hospital holds an extraordinary volume of information about itself. Patient volumes, financial performance, quality measures, service line trends, scheduling patterns and operational capacity are all visible, often in near real time. Leadership hears directly and continuously from employees, physicians, patients and board members. Internal reporting is rarely the constraint.
The constraint is that an organization observes its own performance directly and every competitor’s through inference. Three things in particular remain unavailable from a single vantage point, regardless of how well the market is understood.
Comparison under one methodology. Benchmarking an organization against each competitor on identical criteria, within the same time frame, requires a consistent external standard. Bed size, population trends, quality scores, online reputation, service line presence and paid media investment are all knowable individually. Assembling them for every competitor at once, measured the same way, is a different exercise.
The quantified flow of volume. How much inpatient and outpatient volume left the primary service area in a given year, which service lines it moved toward, and what portion is realistically recoverable are questions that experience can estimate but cannot settle. A board evaluating a capital request needs the figure rather than the estimate.
The community’s own account. Residents answer an independent, anonymous survey differently than they answer the institution that serves them. The distance between those two accounts is both measurable and instructive, and no organization can close it by asking the question itself.
None of these describes a knowledge gap. Each describes a measurement gap, which is a materially different problem requiring a materially different remedy.
Confirmation is a legitimate outcome
Research carries an implicit expectation that its value lies in surprise, when in practice the most useful result is frequently confirmation.
A chief executive who already believes that a competitor is gaining ground, or that the organization’s reputation has not kept pace with genuine improvements in patient experience, gains something specific when analysis attaches a defensible figure to that belief. A belief is difficult to bring into a capital discussion, whereas a quantified opportunity that is sourced and benchmarked can be presented to a board and evaluated on its merits.
Where analysis contradicts an assumption, the value arrives earlier and at lower cost. Learning that a service line assumed to be recoverable is in fact constrained by capacity, or that an apparent reputational problem is a capability problem instead, changes the investment before the investment is committed.
What two engagements demonstrated
Two anonymized MAPS+ engagements illustrate the point from opposite directions. The first involved a regional health system of roughly 400 beds, the clear leader across a multi-county service area. Its own patient-experience data placed it near the top of the industry. Independent community research returned a Net Promoter Score well below benchmark, with preference driven more by convenience than by loyalty. Residents described the system as accessible and, in their own words, disconnected. The care was excellent, and community perception had simply not caught up with it. That finding reframed the problem from a capability question into a communications question, and the two call for very different investments.
The second involved a 25-bed independent community hospital with more than fifty-five years in its market and the highest patient ratings of any system nearby. Its overall Net Promoter Score of 42 compared favorably with a benchmark of 38. The overall figure, however, concealed the more useful finding: loyalty measured 55 among patients aged 65 and older and 33 among younger patients. The same analysis showed cancer care and cardiology routinely moving to an academic center thirty to sixty-five miles away.
Neither engagement produced a revelation about the shape of its market, though both produced something more practical: a defensible account of magnitude, and a clear view of where recovery was realistic.
The relationships matter as much as the findings
Market analysis is frequently reduced to a single question about market share. That number matters, though on its own it says surprisingly little about what leadership should do next.
A more useful view addresses a broader set of questions. Which pressures are specific to this organization, and which affect the sector as a whole. How the organization compares with competitors measured the same way. How the service area is changing. Where volume is leaving, and what portion can realistically return. How the community perceives the organization. Which competitive position can credibly be owned. Whether access, scheduling or capacity constrain growth independent of marketing. Whether marketing investment is directed toward the opportunities the evidence supports. What should happen first, what should follow, and what investment each phase requires.
The value of answering all of them together lies less in the additional data than in the relationships among it. A service line showing significant outmigration does not automatically represent a growth opportunity. Capacity may be constrained. Consumer preference may favor a competitor for reasons unrelated to clinical quality. Demographic trends may be moving against the service line entirely. Those findings examined in isolation frequently support a conclusion that the integrated view does not.
That integration is the organizing principle behind the MAPS+ framework, which resolves eleven components — from national landscape and competitive analysis through consumer research, positioning, operational considerations and implementation — into a single roadmap.
Where this work sits relative to enterprise strategy
None of this replaces a strategic plan. A hospital’s strategic plan establishes where the organization intends to grow, which service lines to prioritize, which partnerships or capital investments to pursue, and whether the economics support those decisions. Marketing and positioning strategy answers a different question entirely: how the market will be persuaded to choose this organization over the alternatives available to it.
Answering that question requires an understanding of competitive position, community sentiment, outmigration and the specific opportunities where investment can realistically change behavior. Those findings then become positioning, marketing priorities, activation and measurement.
The two disciplines are sequential rather than substitutable. An enterprise strategy engagement already underway tends to make market analysis more useful, not less, because the organizational direction has been settled. What remains is the work of translating that direction into market action.
When the question is worth asking
Certain moments make this analysis more valuable than others, and a leadership transition is the clearest of them. Timing changes how information is received inside an organization: an independent assessment conducted early in a tenure is generally understood as diligence, establishing the conditions a leader inherited and providing a baseline for the decisions that follow. The same assessment conducted well into a tenure tends to be interpreted differently, as an evaluation of strategies and investments the leadership team has already approved. Commissioning the work early therefore provides both better information and greater latitude in responding to it.
A leadership transition is not the only such moment. A strategic planning cycle, a significant capital decision, the entry of a new competitor into the service area, a service line under review, or the closure of a service line by a neighboring provider each change the market in ways that prior-year assumptions no longer describe. Any of them is a reasonable occasion for a comparative read.
Toward a decision that can be defended
Hospital leadership rarely lacks data. The difficulty lies in determining which data matters, what it means when considered as a whole, and which opportunities warrant the organization’s limited time, attention and capital.
Independent market analysis earns its value in that determination. It confirms what leadership already suspects and makes that conviction fundable. It challenges an assumption before significant resources follow it. It surfaces gaps that internal reporting is structurally unable to see. And it converts an instinct into a quantified opportunity that leadership can carry into a board discussion with confidence.
Understanding a market is an advantage in itself, and measuring it converts that understanding into a basis for action few competitors in the same market will have assembled.
MAPS+ brings market, competitive, consumer and operational intelligence together into a single set of findings and a sequenced roadmap for growth, typically delivered within 60 to 90 days.
Know your market before your competitor does.
Learn what MAPS+ would measure in your market, and where the greatest opportunities may be found.
About the Author
Julie Amor, MHA, Chief Strategy Officer for Onspire Health Marketing, has 35+ years of experience elevating hospital and healthcare brands. An architect of strategy with a proven record in leading strategic growth initiatives, she spearheads our strategy-first approach for hospital marketing, including our industry-leading rural health division. To discuss how we can partner with you to accelerate intelligent growth for your hospital or healthcare organization, contact Julie at 816-595-6723 or jamor@onspirehm.com.